| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 748904 | [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine | 0.0462077035966084 | 0.37559158 |
| NSC 752365 | 2-[6-(4-Hydroxy-3-methoxy-benzylamino)-hexyl]-benzo[de]isoquinoline-1,3-dione para toluen sulphonate | 0.0462077035966084 | 0.29580716 |
| NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 0.0462077035966084 | 0.3334552 |
| NSC 757113 | METHOTREXATE(+/-) | 0.0462077035966084 | 0.30436828 |
| NSC 88915 | Null | 0.0462077035966084 | 0.38362587 |
| NSC 9706 | Triethylenemelamine | 0.0462077035966084 | 0.14420584 |
| NSC 106969 | CENTAUREIDIN | 0.0462077035966088 | 0.45082209 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 0.0462077035966088 | 0.27340634 |
| NSC 127328 | Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- | 0.0462077035966088 | 0.15513629 |
| NSC 128687 | 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) | 0.0462077035966088 | 0.12453211 |